MedTrace Logo

Plasma Concentrations of Prophylactic Cefazolin in Pediatric Patients Undergoing Cardiac Surgery With CPB

NCT03141450 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 18

Last updated 2020-04-06

No results posted yet for this study

Summary

Surgical site infection (SSI) is a serious operative complication that may be associated with any surgical procedures. It increases morbidity and mortality after cardiac surgery. Plasma concentration of prophylactic antibiotic, routinely cefazolin, is altered by effects of cardiopulmonary bypass. This study is conducted to measure the plasma concentrations of cefazolin to determine its adequacy in pediatric patients undergoing elective cardiac surgery with cardiopulmonary bypass including its correlation with the incidence of postoperative SSI.

Conditions

  • Surgical Site Infection

Sponsors & Collaborators

  • Mahidol University

    lead OTHER

Principal Investigators

  • Saowaphak Lapmahapaisan, MD · Mahidol University

Eligibility

Max Age
7 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2018-01-31
Completion
2018-01-31

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03141450 on ClinicalTrials.gov